COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Viscom SE: Weak demand characterises business performance in the first half of 2024; Adjustment of the annual forecast despite continued limited predictability Viscom SE experiences weak demand leading to an adjustment of annual forecast; Incoming orders and revenue decline in the first half of 2024 Forecast Adjustment Business Performance Weak Demand Incoming Orders Viscom SE
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Kuros Biosciences Reports First Half of 2024 Results Kuros Biosciences reports significant growth in H1 2024, with MagnetOs sales up 159% to CHF 31.6 million. FDA clearances and positive outlook indicate continued success in bone healing technologies market Sales Growth Kuros Biosciences MagnetOs H1 2024 FDA Clearances
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Q2 2024 financial figures: Vitesco Technologies improves profitability in a challenging environment Vitesco Technologies Group AG reports improved profitability in Q2 2024 despite challenging market conditions. Sales at €2.02 billion, adjusted EBIT margin of 4.0% Sales Profitability EBIT Vitesco Technologies Q2 2024
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Mister Spex Repositions Brand: 'The Optician of Your Life' Mister Spex SE has repositioned its brand as 'The Optician of Your Life,' focusing on optician expertise and premium lenses to strengthen its leadership position in the optical industry Repositioning Brand Campaign Mister Spex Optician Expertise Premium Lenses
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Branicks Group AG: Further milestone successes for financial consolidation Branicks Group AG reports successful financial consolidation with EUR 94 million cash inflow from share deals and strong operational development, achieving 2024 targets Real Estate Branicks Group AG Share Deals Financial Consolidation Operational Development
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois HAMBORNER REIT AG: Stable business performance in the first half of the year in line with planning - confirmation of full-year forecast for 2024 HAMBORNER REIT AG reports stable business performance in the first half of 2024, with increased rental income and FFO. Full-year forecast for 2024 confirmed Business Performance Rental Income HAMBORNER REIT AG FFO Full-year Forecast
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois KNAUS TABBERT - Strong result in the first half of 2024, Knaus Tabbert brands remain market leader for motorhomes Knaus Tabbert AG reports strong first half 2024 results with revenue of EUR 699.4 million and brands leading in motorhomes. Updated forecast confirmed Forecast Knaus Tabbert AG Leisure Vehicles Motorhomes First Half Results
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois HIAG Capital Market Day 2024 HIAG Immobilien Holding AG invites associates to Capital Market Day 2024, showcasing diverse property portfolio with site tours and project insights Property Portfolio HIAG Immobilien Capital Market Day 2024 Site Tours Project Insights
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Communiqué : Le traitement d’induction par Sarclisa a démontré une amélioration significative de la survie sans progression chez les patients atteints d’un myélome multiple nouvellement diagnostiqué et éligibles à une transplantation Le traitement d’induction par Sarclisa montre une amélioration significative de la survie sans progression chez les patients atteints de myélome multiple nouvellement diagnostiqués et éligibles à une transplantation Myélome Multiple Sarclisa Survie Sans Progression Traitement D'induction GMMG-HD7
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années 2 mois Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment Multiple Myeloma Sarclisa Progression-free Survival GMMG-HD7 Study Frontline Treatment
Publié le 06/11/2026 à 09:07, il y a 5 heures 9 minutes Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Publié le 06/11/2026 à 09:04, il y a 5 heures 11 minutes Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Publié le 05/11/2026 à 18:21, il y a 19 heures 54 minutes Capital et droits de vote au 31 octobre 2026
Publié le 06/11/2026 à 13:00, il y a 1 heure 16 minutes Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Publié le 06/11/2026 à 12:30, il y a 1 heure 46 minutes Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Publié le 06/11/2026 à 12:30, il y a 1 heure 46 minutes Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Publié le 06/11/2026 à 05:15, il y a 9 heures 1 minute Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Publié le 06/11/2026 à 12:02, il y a 2 heures 14 minutes First close-up asteroid image as ESA spacecraft built by OHB approaches historic rendezvous with the Didymos system
Publié le 06/11/2026 à 11:44, il y a 2 heures 32 minutes Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions
Publié le 06/11/2026 à 11:41, il y a 2 heures 35 minutes Turkiye Garanti Bankasi A.S.: The Capital Increase of our Bank’s subsidiary Garanti Finansal Kiralama A.S